Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study María del Carmen Bermúdez-Ruiz; Irene Vilar Sánchez; Clara Aparicio Pérez; Rosario Carmona Flores; Jorge Rodríguez-Gómez; Carmen de la Fuente-Martos;

Anti-Xa activity below range is related to thrombosis in patients with severe COVID-19 Pilar Marcos-Neira; Cristian Morales-Indiano; Mariana Fernández-Caballero; Teresa Tomasa-Irriguible; Luisa Bordejé-Laguna; Víctor Ruíz-Artola;

Experience with ECMO therapy for acute respiratory distress syndrome treatment throughout the COVID-19 pandemic José María Arribas-Leal; José Miguel Rivera-Caravaca; Claudia Vicente-Andreu; Alicia Verdú-Verdú; Ángel Sornichero; Daniel Pérez-Martínez; Juan Blanco-Morillo; Francisco Gutiérrez; Marina Simón-Páez; Rubén Jara; Sergio J. Canovas-Lopez; Carlos Albacete-Moreno;